April 15, 2024
Monday April 15, 2024 – 4pm – Salle Couvreur
Zhifen WANG - Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR) - Cellular and Molecular Pharmacology (FACM)
Evaluation of Antibiotics and Adjuvant Strategies Against Dual Species Biofilms in the Context of Cystic Fibrosis
Promotor: Prof. Françoise Van Bambeke
Related references:
- Wang Z, Vanbever R, Lorent JH, Solis J, Knoop C, Van Bambeke F. Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics. J Cyst Fibros. doi:10.1016/j.jcf.2024.02.012
- Wang Z, Giedraitis E, Knoop C, Breiner D. J., Phelan, V. V., Van Bambeke F. Reciprocal adaptation of Staphylococcus aureus and Pseudomonas aeruginosa co-isolated from same patients with Cystic Fibrosis in a new model of dual species biofilm grown in artificial sputum medium (Submitted)
- Wang Z & De Soir S, Glorieux A, Merabishvili M, C. Knoop, De Vos D, Pirnay JP, Van Bambeke F. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa (Submitted)